In this work, we explored the effects of IDH1R132H on NAD+ metabolism and the therapeutic potential of NAMPT knockdown and NAMPT small-molecule inhibitors in IDH1wt and IDH1R132H glioma cells. The gene discussed is NAMPT; the disease is glioma.